American Association for Cancer Research

Skip to Main Content

Table 2

Patients develop DTH at the vaccination site

DTH responses were measured and recorded 48 h after each vaccine administration.
	Induration (mm) at 48 h
Patients	DTH: vaccine 1	DTH: recent vaccine
ECD
VC9421	None	Confluent 80 × 64
LR3530	None	23/22
KK8169	None	Not available^a
CZ8474	None	Confluent 60 × 75
ICD
TS5437	None	10/14
ER9519	Red, warm. No induration.	20/16
DG4965	None	22/18
CC7062	None	Confluent 48 × 59

DTH responses were measured and recorded 48 h after each vaccine administration.
	Induration (mm) at 48 h
Patients	DTH: vaccine 1	DTH: recent vaccine
ECD
VC9421	None	Confluent 80 × 64
LR3530	None	23/22
KK8169	None	Not available^a
CZ8474	None	Confluent 60 × 75
ICD
TS5437	None	10/14
ER9519	Red, warm. No induration.	20/16
DG4965	None	22/18
CC7062	None	Confluent 48 × 59

^a

Patient reported “small lump” in inoculation site, not measured.